Scholars@Duke
Journal cover image

From the Food and Drug Administration.

Publication ,  Journal Article
McClellan, MB
Published in: JAMA
November 2002
Published version (DOI)

Duke Scholars

Mark B McClellan
Author Mark B McClellan Fuqua School of Business

Published In

JAMA

DOI

10.1001/jama.288.17.2112-jfd20011-2-1

EISSN

1538-3598

ISSN

0098-7484

Publication Date

November 2002

Volume

288

Issue

17

Start / End Page

2112

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Triazoles
  • Organophosphonates
  • Nitriles
  • Humans
  • Hepatitis B, Chronic
  • General & Internal Medicine
  • Chemotherapy, Adjuvant
  • Breast Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McClellan, M. B. (2002). From the Food and Drug Administration. JAMA, 288(17), 2112. https://doi.org/10.1001/jama.288.17.2112-jfd20011-2-1
McClellan, Mark B. “From the Food and Drug Administration.” JAMA 288, no. 17 (November 2002): 2112. https://doi.org/10.1001/jama.288.17.2112-jfd20011-2-1.
McClellan MB. From the Food and Drug Administration. JAMA. 2002 Nov;288(17):2112.
McClellan, Mark B. “From the Food and Drug Administration.” JAMA, vol. 288, no. 17, Nov. 2002, p. 2112. Epmc, doi:10.1001/jama.288.17.2112-jfd20011-2-1.
McClellan MB. From the Food and Drug Administration. JAMA. 2002 Nov;288(17):2112.
Journal cover image

Published In

JAMA

DOI

10.1001/jama.288.17.2112-jfd20011-2-1

EISSN

1538-3598

ISSN

0098-7484

Publication Date

November 2002

Volume

288

Issue

17

Start / End Page

2112

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Triazoles
  • Organophosphonates
  • Nitriles
  • Humans
  • Hepatitis B, Chronic
  • General & Internal Medicine
  • Chemotherapy, Adjuvant
  • Breast Neoplasms